115 related articles for article (PubMed ID: 3144700)
1. Surrogate testing for non-A, non-B hepatitis in Queensland, Australia: an ALT microtitre tray method for screening blood donors.
Hyland CA; Douglas R; Mazzocchi R; Young IF
Pathology; 1988 Jul; 20(3):271-4. PubMed ID: 3144700
[TBL] [Abstract][Full Text] [Related]
2. Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipients.
Mishler JM; Barbosa L; Mihalko LJ; McCarter H
JAMA; 1981 Nov; 246(20):2340-4. PubMed ID: 6795368
[TBL] [Abstract][Full Text] [Related]
3. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
[TBL] [Abstract][Full Text] [Related]
4. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
5. [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
Grunenberg R; Banik N; Krüger J
Infusionsther Transfusionsmed; 1995 Jun; 22(3):145-51. PubMed ID: 7640509
[TBL] [Abstract][Full Text] [Related]
6. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
[TBL] [Abstract][Full Text] [Related]
7. Screening of donor blood for alanine aminotransferase.
Fiedler H
JAMA; 1985 Dec; 254(24):3422. PubMed ID: 3934400
[No Abstract] [Full Text] [Related]
8. Evaluation of blood donors with elevated serum alanine aminotransferase levels.
Friedman LS; Dienstag JL; Watkins E; Hinkle CA; Spiers JA; Rieder SV; Huggins CE
Ann Intern Med; 1987 Aug; 107(2):137-44. PubMed ID: 3111321
[TBL] [Abstract][Full Text] [Related]
9. Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum--a possible indicator of non-A, non-B hepatitis.
Emmanuel JC; Bassett MT; Smith HJ; Paterson LE
Cent Afr J Med; 1989 Aug; 35(8):469-70. PubMed ID: 2509075
[No Abstract] [Full Text] [Related]
10. Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state.
Brotman B; Prince AM
Vox Sang; 1988; 54(3):144-7. PubMed ID: 2897145
[TBL] [Abstract][Full Text] [Related]
11. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.
Silverstein MD; Mulley AG; Dienstag JL
JAMA; 1984 Nov 23-30; 252(20):2839-45. PubMed ID: 6436522
[TBL] [Abstract][Full Text] [Related]
12. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
[TBL] [Abstract][Full Text] [Related]
13. Post-transfusion viral hepatitis and the TTVS.
Holland PV; Bancroft W; Zimmerman H
N Engl J Med; 1981 Apr; 304(17):1033-5. PubMed ID: 6782483
[No Abstract] [Full Text] [Related]
14. Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden.
Widell A; Sundström G; Hansson BG; Fex G; Moestrup T; Nordenfelt E
Vox Sang; 1988; 54(3):154-9. PubMed ID: 3130727
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L.
Notari EP; Orton SL; Cable RG; Grindon AJ; Lenes BA; Williams AE; McMillan KM; Trouern-Trend JJ; Wolf-Nugent JS; Xu YL; Dodd RY;
Transfusion; 2001 Jun; 41(6):751-5. PubMed ID: 11399814
[TBL] [Abstract][Full Text] [Related]
16. The distribution of serum alanine aminotransferase levels in a blood donor population.
Kahn RA; Johnson G; Aach RD; Hines A; Ellis FR; Miller WV
Am J Epidemiol; 1982 Jun; 115(6):929-40. PubMed ID: 6807084
[TBL] [Abstract][Full Text] [Related]
17. Donor transaminase and recipient hepatitis. Impact on blood transfusion services.
Alter HJ; Purcell RH; Holland PV; Alling DW; Koziol DE
JAMA; 1981 Aug; 246(6):630-4. PubMed ID: 6788964
[TBL] [Abstract][Full Text] [Related]
18. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
Zawde D; Sisay Y
Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
[TBL] [Abstract][Full Text] [Related]
19. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857
[No Abstract] [Full Text] [Related]
20. Indirect tests to detect the non-A, non-B hepatitis carrier state.
Alter HJ; Holland PV
Ann Intern Med; 1984 Dec; 101(6):859-61. PubMed ID: 6437311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
